Drug
Vodobatinib
Vodobatinib: highest development phase Phase 1/2, developed by Sun Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Sun Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Vodobatinib (K0706) capsules NCT02629692 | Phase 1/2 | Healthy (For Part A) |
Latest
No recent events.
Follow Vodobatinib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.